Correspondingly, it was demonstrated that IL-38 showed suppressive impacts on LPS-mediated TLR4 secretion, leading to an attenuated inflammation in patients with RA through inhibition of the activation of NF-κB [120]. This evidence concerns the gene IL1F10 and rheumatoid arthritis.